Cargando…
The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy
BACKGROUND: Neoadjuvant chemotherapy (NeoCTx) is performed for most patients with colorectal cancer liver metastases (CRCLM). However, chemotherapy-associated liver injury (CALI) has been associated with poor postoperative outcome. To date, however, no clinically applicable and noninvasive tool exis...
Autores principales: | Pereyra, D., Rumpf, B., Ammann, M., Perrodin, S. F., Tamandl, D., Haselmann, C., Stift, J., Brostjan, C., Laengle, F., Beldi, G., Gruenberger, T., Starlinger, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373283/ https://www.ncbi.nlm.nih.gov/pubmed/30617869 http://dx.doi.org/10.1245/s10434-018-07125-6 |
Ejemplares similares
-
Combined APRI/ALBI score to predict mortality after hepatic resection
por: Starlinger, P, et al.
Publicado: (2021) -
Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis
por: van Kessel, Charlotte S., et al.
Publicado: (2012) -
ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection
por: Pereyra, D., et al.
Publicado: (2019) -
Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation
por: Starlinger, P, et al.
Publicado: (2012) -
Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)